Delfini Logo
Evidence- and Value-based Solutions for Health Care™
Clinical Improvement Consults, Content Development, Training & Seminars, Tools

Publication: Creating evidence-based drug monographs and drug class reviews

The EBM Information Quest: Is it true? Is it useful? Is it usable?™

Delfini Co-founders: Michael E Stuart MD, President & Medical Director . Sheri Ann Strite, Managing Director & Principal

Quick Picks

Delfini: Dr. Michael E. Stuart & Sheri Ann Strite
Why Critical Appraisal Matters



Contact Us
Updates & Contact Info

Free Online Tools

Free Online Tutorial

Delfini Blog

EBM Dolphin
Evidence & Quality Improvement Commentaries


Follow & Share...

Just-in-time UpdatesFollow Delfini Group on Twitter

Like Us Like Us on Facebook  Find UsFind Us at LinkedIn

Formulary: Creating evidence-based drug monographs and drug class reviews

Formulary®: a peer-reviewed drug management journal for managed care and hospital decision-maker

DelfiniGram™: GET ON OUR UPDATE LIST Contact Us

Process steps and suggestions for creating drug monographs and drug class reviews in an evidence-based formulary system

Strite SA, Stuart ME, Urban S. Process steps and suggestions for creating drug monographs and drug class reviews in an evidence-based formulary system. Formulary. April 2008;43:135–145.

Given the high estimates of inappropriate healthcare decisions in this country and the well-documented evidence of inappropriate variations in healthcare, a well-functioning formulary system is of great importance. Bias in research tends to inflate or falsely report benefit in clinical trials of interventions by up to a relative 40% to 50%. Therefore, to ensure the adoption of products with valid and clinically useful outcomes, formulary systems should include in their processes the key steps used in evidence-based medicine, including the evaluation of therapeutic studies for bias and clinical usefulness to inform formulary decisions. This article outlines requirements and suggestions for obtaining studies with appropriate designs and acceptable methodology and execution, and emphasizes why such studies should be the basis for developing drug monographs and class reviews and informing decisions. (Formulary. 2008;43:135–145.)

Online and downloadable version [PDF]


CONTACT DELFINIContact UsCONTACT DELFINI Delfini Group EBM DolphinDelfini Group EBM Dolphin

At Publications: EB Monographs

EBM Delfini boat

Read Our Blog...

Use of our website implies agreement to our Notices. Citations for references available upon request.

Best of Delfini
What's New


Delfini Group Publishing
Sample Projects
About Us & Our Work
Site Search

Contact Info/Updates


Quick Navigator to Selected Resources


Return to Top

© 2002-2020 Delfini Group, LLC. All Rights Reserved Worldwide.
Use of this website implies your agreement to our Notices.

EBM Solutions for Evidence-based Health Care Quality